GridAI Technologies (GRDX) Interest Expenses (2015 - 2025)
GridAI Technologies' (GRDX) quarterly Interest Expenses came in at $149381.0 in Q4 2025, up 2522.1% YoY from $5697.0 in Q4 2024, and down 93.35% on a QoQ basis from $2.2 million in Q3 2025.
GridAI Technologies (GRDX) Interest Expenses (2015 - 2025) Analysis & Trends
GridAI Technologies (GRDX) has 11 years of Interest Expenses data on file, last reported at $149381.0 in Q4 2025.
- Quarterly Interest Expenses rose 2522.1% year-over-year to $149381.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $149381.0 (up 531.9% YoY) and the FY2025 annual result came in at $2.3 million, down 93.89% from the prior year.
- Interest Expenses declined to $149381.0 in Q4 2025, from $2.2 million in the prior quarter.
- In the past five years, Interest Expenses ranged from a high of $2.2 million in Q3 2025 to a low of $2395.0 in Q4 2021.
- A 5-year average of $403305.7 and a median of $277943.0 in 2023 frame the typical range for Interest Expenses.
- The widest YoY moves for Interest Expenses: up 2522.1% in 2025, down 97.5% in 2025.
- Tracing GRDX's Interest Expenses over 5 years: stood at $2395.0 in 2021, then jumped by 158.58% to $6193.0 in 2022, then surged by 51.06% to $9355.0 in 2023, then plunged by 39.1% to $5697.0 in 2024, then soared by 2522.1% to $149381.0 in 2025.
- The last three Interest Expenses figures came in at $149381.0 (Q4 2025), $2.2 million (Q3 2025), and $17902.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 11.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 39.74 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 82.05 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 20.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 93.62 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -4.89 Mn |
| 10 | GridAI Technologies | 6.06 Mn | 6.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 149,381.00 |
| Dec 31, 2025 | 149,381.00 |
| Sep 30, 2025 | 2.25 Mn |
| Sep 30, 2025 | 2.25 Mn |
| Mar 31, 2025 | 17,902.00 |
| Mar 31, 2025 | 17,902.00 |
| Dec 31, 2024 | 5,697.00 |
| Dec 31, 2024 | 5,697.00 |
| Sep 30, 2024 | 171,196.00 |
| Sep 30, 2024 | 171,196.00 |
| Jun 30, 2024 | 84,274.00 |
| Jun 30, 2024 | 84,274.00 |
| Mar 31, 2024 | 716,350.00 |
| Mar 31, 2024 | 716,350.00 |
| Dec 31, 2023 | 9,355.00 |
| Dec 31, 2023 | 9,355.00 |
| Sep 30, 2023 | 277,943.00 |
| Sep 30, 2023 | 277,943.00 |
| Jun 30, 2023 | 277,943.00 |
| Jun 30, 2023 | 277,943.00 |